Health
Pfizer’s vaccine was 91% effective in children ages 5 to 11, according to a new study – OI Canadian
Pfizer in children aged 5 to 11 years detected a high efficacy, estimated at 91% (Shawn Rocco / Duke University / Handout via…
A trial conducted with the laboratory’s COVID-19 vaccine Pfizer in children from 5 to 11 years detected a high efficacy, estimated at 91%, in addition to a strong immune response and no serious side effects.
The analysis was carried out in 2,268 participants,…
Continue Reading